<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-164124</identifier>
<setSpec>0212-1611</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Iodine levels are associated with oxidative stress and antioxidant status in pregnant women with hypertensive disease</dc:title>
<dc:description xml:lang="en">Background: The antioxidant function of iodine and iodine deficiency as a risk factor of preeclampsia have been previously reported. Aim: To analyze the association between iodine deficiency, oxidative stress and antioxidant status with hypertensive disease of pregnancy (HPD). Method: Fifty-seven pregnant women were recruited in the last trimester of pregnancy; 20 were diagnosed with hypertensive disease (HPD) of pregnancy and 37 were normotensive pregnant women. Urinary iodine concentration (UIC), TSH, free T4 (fT4), total antioxidant status (FRP), superoxide dismutase (SOD), catalase (CAT), and oxidative stress (TBARS) were evaluated by colorimetric methods. Results: UIC median for all pregnant women was 151.9 &amp;#956;g/l. The UIC for pregnant women with HPD was 50-149 &amp;#956;g/l, compared to 150-249 &amp;#956;g/l in normotensive women. No significant differences in levels of TSH and fT4 in normotensive pregnant compared with HPD women were found. Pregnant women with HPD had significant high levels of TBARS, and significant low levels of FRP, SOD, CAT and UIC compared to normotensive pregnant. In addition, pregnant women with optimal levels of UIC had a higher SOD activity (r = 0.354, p = 0.011), while iodine deficiency was associated with HPD (r = -0,281, p = 0.039). Similarly, pregnant women with HPD had a significant negative association with SOD activity (r = -0.702, p = 0.005), CAT (r = -0.409, p = 0.002), and FRP (r = -0.624, p = 0.003), and a positive association with TBARS (r = 0.744, p = 0.001). Conclusion: Iodine contributes to redox balance during pregnancy; its deficiency is associated with HPD. This study shows the importance of iodine during pregnancy (AU)</dc:description>
<dc:creator>Cuellar-Rufino, Sergio</dc:creator>
<dc:creator>García-Solís, Pablo</dc:creator>
<dc:creator>Xochihua-Rosas, Irene</dc:creator>
<dc:creator>Arroyo-Helguera, Omar</dc:creator>
<dc:creator>Navarro-Meza, Mónica</dc:creator>
<dc:language>en</dc:language>
<dc:description xml:lang="es">Antecedentes: previamente se han reportado la función antioxidante del yodo y su deficiencia como un factor de riesgo de preeclampsia. Objetivo: analizar la asociación entre la deficiencia de yodo, el estrés oxidativo y el estado antioxidante con la enfermedad hipertensiva del embarazo (HPD). Métodos: cincuenta y siete mujeres embarazadas se reclutaron en el último trimestre del embarazo, 20 diagnosticadas de enfermedad hipertensiva del embarazo y 37 gestantes normotensas. La concentración urinaria de yodo (UIC), TSH, T4 libre (hT4), estado antioxidante total (FRP), superóxido dismutasa (SOD), catalasa (CAT), y estrés oxidativo (TBARS) se evaluaron por métodos colorimétricos. Resultados: la mediana de UIC para todas las mujeres embarazadas fue de 151,9 &amp;#956;g/l. La UIC para las mujeres embarazadas con HPD fue de entre 50 y 149 &amp;#956;g/l, comparada con 150-249 &amp;#956;g/l de las gestantes normotensas. No se encontraron diferencias significativas entre los niveles de TSH y fT4 en embarazadas normotensas y en mujeres con HPD. Las mujeres embarazadas con HPD tuvieron niveles altos de TBARS y niveles bajos de FRP, SOD, CAT y UIC comparadas con las gestantes normotensas. Además, las mujeres gestantes con niveles óptimos de UIC tuvieron la actividad SOD más alta (r = 0,354, p = 0,011), mientras que la deficiencia de yodo se asoció con HPD (r = -0,281, p = 0,039). De manera similar, las gestantes con HPD tuvieron una asociación negativa con la actividad de SOD (r = -0,702, p = 0,005), CAT (r = -0,409, p = 0,002) y FRP (r = -0,624, p = 0,003), y una asociación positiva con TBARS (r = 0,744, p = 0,001). Conclusión: el yodo coadyuva en el balance redox durante la gestación; su deficiencia está asociada con HPD. Este estudio muestra la importancia del yodo durante la gestación (AU)</dc:description>
<dc:source>Nutr Hosp;34(3): 661-666, mayo-jun. 2017. tab</dc:source>
<dc:identifier>ibc-164124</dc:identifier>
<dc:title xml:lang="es">Los niveles de yodo están asociados con estrés oxidativo y estado antioxidante en mujeres embarazadas con enfermedad hipertensiva</dc:title>
<dc:subject>^d22261</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d32101^s22021</dc:subject>
<dc:subject>^d979^s22031</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d11662^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d24551</dc:subject>
<dc:subject>^d11688^s22057</dc:subject>
<dc:subject>^d7152^s22057</dc:subject>
<dc:subject>^d22697^s22002</dc:subject>
<dc:subject>^d16596^s22057</dc:subject>
<dc:subject>^d16596^s22054</dc:subject>
<dc:subject>^d3155^s22045</dc:subject>
<dc:subject>^d11688^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>201706</dc:date>
</metadata>
</record>
</ibecs-document>
